Physician profile
Jubie Vinu
NPI 1316375512
$3,726.37
in general payments reported to CMS, 2019-2025
21 companies · $662 in 2025
The $662 reported for 2025 was more than what 78% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $428 · 2022: $828 · 2023: $1,067 · 2024: $742 · 2025: $662.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,272 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,271.50 |
| Education | $198.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,238.89 | 2021-2025 | |
| Lundbeck LLC | $613.06 | 2023-2025 | Vyepti |
| Teva Pharmaceuticals USA, INC. | $342.91 | 2022-2025 | Ajovy, Austedo |
| Janssen Pharmaceuticals, INC | $249.49 | 2022-2023 | Xarelto |
| Sk Life Science, INC. | $216.92 | 2021-2025 | |
| Pfizer INC. | $157.88 | 2023-2025 | |
| Neurocrine Biosciences, INC. | $138.44 | 2022-2025 | Ongentys, Ingrezza |
| Biohaven Pharmaceuticals, INC. | $128.52 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $104.00 | 2023 | Jynarque |
| Livanova USA, INC. | $82.02 | 2025 | Vns Therapy Sentiva Model 1000 Generator, Vns Therapy |
| Gilead Sciences, INC. | $77.38 | 2022 | |
| Harmony Biosciences LLC | $67.48 | 2021-2022 | |
| Genentech USA, INC. | $56.38 | 2021-2022 | |
| Amgen INC. | $49.16 | 2022-2023 | Aimovig |
| Biogen, INC. | $47.58 | 2023 | Vumerity, Tysabri |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $40.75 | 2025 | Fintepla |
| Ge Healthcare | $37.58 | 2021 | |
| Allergan, INC. | $29.22 | 2022 | |
| Lilly USA, LLC | $18.71 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $16.00 | 2022 | |
| Novartis Pharmaceuticals Corporation | $14.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jubie Vinu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.